FDA-Drug2015-01-07Class II
GINSENG KIANPI PIL, 60 capsules, PRODUCT OF KWEILIN DRUG MANUFACTORY
One and Zen
Hazard
Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared dexamethasone and cyproheptadine which are FDA approved drugs making this product an unapproved drug.
Sold states
Nationwide
Affected count
38 bottles
Manufactured in
1339 San Mateo Blvd Se, Apt 2, Albuquerque, NM, United States
Products
GINSENG KIANPI PIL, 60 capsules, PRODUCT OF KWEILIN DRUG MANUFACTORY
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0329-2015Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief